Back
Speaker illustration

undefined undefined undefined

Presentations

Heart failure with improved ejection fraction (HFimpEF) in patients treated with sacubitril/valsartan (SV)

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Heart failure pharmacotherapy - Sacubitril/valsartan

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources